Rivastigmin "Stada" 6 mg kapsler, h?rde Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

rivastigmin "stada" 6 mg kapsler, h?rde

stada arzneimittel ag - rivastigminhydrogentartrat - kapsler, hårde - 6 mg

Acivir 50 mg/g creme Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

acivir 50 mg/g creme

stada arzneimittel ag - aciclovir - creme - 50 mg/g

Rivastigmin "Stada" 1,5 mg kapsler, h?rde Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

rivastigmin "stada" 1,5 mg kapsler, h?rde

stada arzneimittel ag - rivastigminhydrogentartrat - kapsler, hårde - 1,5 mg

Nizoral 2 % shampoo Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

nizoral 2 % shampoo

stada arzneimittel ag - ketoconazol - shampoo - 2 %

Aciclodan 50 mg/g creme Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

aciclodan 50 mg/g creme

stada arzneimittel ag - aciclovir - creme - 50 mg/g

Dorzolamid "STADA" 20 mg/ml øjendråber, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

dorzolamid "stada" 20 mg/ml øjendråber, opløsning

stada arzneimittel ag - dorzolamidhydrochlorid - øjendråber, opløsning - 20 mg/ml

Hirudoid 3 mg/g gel Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

hirudoid 3 mg/g gel

stada arzneimittel ag - mucopolysaccharidpolysvovlsyreester - gel - 3 mg/g

Hirudoid 3 mg/g salve Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

hirudoid 3 mg/g salve

stada arzneimittel ag - mucopolysaccharidpolysvovlsyreester - salve - 3 mg/g

Nizoral 1% shampoo Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

nizoral 1% shampoo

stada arzneimittel ag - ketoconazol - shampoo - 1%

Clopidogrel Acino Den Europæiske Union - dansk - EMA (European Medicines Agency)

clopidogrel acino

acino ag - clopidogrel - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - antitrombotiske midler - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , , , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease, non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa), st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy, patients suffering from acute coronary syndrome. , ,.